World Pharma Today
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
MEDIAPACK
Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Vector Development for Cell and Gene Therapy Summit 2022
Latest News and Updates

A Gene Causing Persistent Pain Discovered By Oxford Team

According to the most recent research, any medication that can increase the activity of NCX3 has the potential to reduce the pain sensitivity faced by people.

READ MORE

Blood Vessel Breakthrough Helps Treatment of Alzheimer's

By showing how exactly Alzheimers affects small blood vessels, new research can be termed as breakthrough to being close to the exact treatment of the disease.

READ MORE

 


Aquatic Millirobot From Stanford Rolls, Flips, And Spins

These fingertip-sized robots have the ability to save lives in the future by crawling, spinning, and swimming into tight locations and also distribute drugs.

READ MORE

Sydney Applauds NSW Financing For Biomedical Research

Being hospital-university ecosystem, SBA will bring global cluster of biomedical research talent and facilities and will be positioned for industry, start-ups.

READ MORE

 


Third Rock Raises $1Bn In Life Sciences Amid Biotech Slump

Third Rock Ventures has decided to go ahead with a whopping $1bn funding in the biotech landscape despite the consistent slump which the sector is witnessing.

READ MORE
COVID-19 Updates

FDA Has Approved Pfizer, Moderna COVID-19 Shots For Kids

The FDA approved Pfizer and Moderna COVID-19 injections for kids as young as six months old, a decision that parents, carers, and doctors had been waiting for.

READ MORE

 


Bharat Biotech Ends Clinical Trial Of Nasal COVID-19 Vaccine

Following the completion of clinical trials, the data analysis of the nasal vaccine is currently on after which they shall seek the permission to launch it.

READ MORE

Pfizer To Buy 8.1% Equity In Valneva, A French Vaccine Firm

To finance the phase 3 development commitment to its lyme disease program, Valneva intends to use proceeds from the equity investment that is made by Pfizer.

READ MORE

Vector Development for Cell and Gene Therapy Summit 2022
 
Advertising:

kathryn@worldpharmatoday.com

Phone: + 91 88268 49084


  For the latest visit: https://www.worldpharmatoday.com/

World Pharma Today